U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159789) titled 'Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis' on Aug. 29.
Brief Summary: Study the impact of rTMS on walking ability in people with Multiple Sclerosis (MS) induced spastic paraparesis and moderate walking disability.
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Multiple Sclerosis
Intervention:
DEVICE: Repetitive Transcranial Magnetic Stimulation
Treatment with the rTMS or sham rTMS will be scheduled daily 5x per week for a total of 6 consecutive weeks followed, after a 6 week pause, by another treatment session of 6 weeks where all patients will receive active rTMS t...